Cargando…
Duloxetine-related posterior reversible encephalopathy syndrome: A case report
BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) has well-established links with several drugs. Whether a link also exists with serotonin–norepinephrine reuptake inhibitor such as duloxetine is unclear. METHODS: We report on a patient who developed PRES with a coma and myoclonus relat...
Autores principales: | Zappella, Nathalie, Perier, François, Pico, Fernando, Palette, Catherine, Muret, Alexandre, Merceron, Sybille, Girbovan, Andrei, Marquion, Fabien, Legriel, Stephane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370806/ https://www.ncbi.nlm.nih.gov/pubmed/27537580 http://dx.doi.org/10.1097/MD.0000000000004556 |
Ejemplares similares
-
Posterior reversible encephalopathy syndrome with essential thrombocythemia: A case report
por: Zhang, Yunqiao, et al.
Publicado: (2019) -
Posterior reversible encephalopathy syndrome in a patient with late postpartum eclampsia
por: Zhu, Manmin, et al.
Publicado: (2023) -
Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated spinal subdural hematoma: A case report
por: Chen, Hanfeng, et al.
Publicado: (2020) -
Posterior reversible encephalopathy syndrome (PRES) in a patient with moyamoya disease: A case report
por: Teng, Chun-Hsin, et al.
Publicado: (2021) -
Posterior reversible encephalopathy syndrome after postpartum hemorrhage and uterine artery embolization: A case report
por: Shi, Fangfang, et al.
Publicado: (2017)